You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科濟藥業-B(02171.HK):Richard John Daly獲委任為公司旗下美國子公司總裁
格隆匯 01-17 08:06

格隆匯1月17日丨科濟藥業-B(02171.HK)發佈公吿,Richard John Daly被委任為公司旗下美國子公司CARsgen Therapeutics Corporation的總裁,向科濟藥業的創始人、董事長、首席執行官及首席科學家李宗海彙報。Daly先生將領導科濟藥業美國團隊處理科濟藥業在中國外的國際商業活動,包括臨牀開發,製造運營,業務發展,商業化,投資者關係及公共關係。Daly先生也將對科濟藥業的總體戰略增長和業務計劃作出貢獻,幫助公司為全世界的癌症患者發展更多創新和差異化的細胞治療方案並使癌症得以治癒。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account